Press releases
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares and Pre-Funded Warrants
Quotient Limited Provides Fourth Quarter Fiscal 2022 Results and Business Update
Quotient Limited Announces Pricing of Underwritten Offering
Quotient Limited Announces Proposed Underwritten Offering
Quotient Limited Announces Proposed Amendments to Senior Secured Notes
Quotient Limited Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials
• Pre-announces FY 2022 revenue of $38.5 million

• Secured $1.4 million of orders in Q1 FY23 for recently CE Marked Extended IH MosaiQ Solution

• $83.2 million in cash and investments as of March 31, 2022
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
- Partnership brings together novel technology and clinical applications expertise to produce automated, multiplexed solutions for advancing autoimmune diagnostics

- Expands access to $2 billion autoimmune IVD specialty market with MosaiQ

- Targeted market introduction…
Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution
Virtual event on Monday, May 23rd at 11:00 AM ET

The webinar will provide a detailed discussion on the current landscape and unmet needs within blood grouping and donor disease screening
Quotient Limited Announces Appointment of New Board Member